Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftobiprole OATP1B interaction study
NL-OMON60159Phase 1Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- Jan 2025
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of ceftobiprole medocaril in community acquired pneumonia (CAP), sponsored by Basilea Pharmaceutica. Started Jan 2025; status: completed.
02
Drugs
ceftobiprole medocaril
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NL-OMON60159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60159.